Articles

Nutrition intervention can help minimize the number of complications patients may experience during oncology treatment. Read More ›

In this month’s issue of The Oncology Nurse-APN/PA (TON), we wrap up our coverage of the news from the recent Oncology Nursing Society (ONS) 40th Annual Congress and the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO). Read More ›

The number of genes associated with breast cancer risk continues to increase. Recently, through whole exome sequencing, 2 groups of researchers have demonstrated that mutations in RECQL increase the risk of breast cancer. Read More ›

The Oncology Nurse–APN/PA conducted an interview with Jennifer Temel, MD. The written interview is based on a presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology, Phase III Trials for Anamorelin in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia (ROMANA 1 and 2). Read More ›

Antibody-drug conjugates (ADCs) offer a unique approach for the treatment of solid tumors and hematologic cancers. The idea is that a potent cytotoxic agent is linked to an antibody specifically targeted to tumor cells, and once the antibody binds to the tumor cell, the cytotoxic agent is unleashed inside the cells to attack the cancer. Read More ›

Treatment for chronic lymphocytic leukemia (CLL) has come a long way with the availability of new drugs that improve outcomes. As new treatments become available, there is a corresponding learning curve. Read More ›

Approximately 40% of patients treated with anthracyclines are still not receiving National Comprehensive Cancer Network (NCCN) guideline–adherent prophylaxis for chemotherapy-induced vomiting. Read More ›

In this month’s issue of The Oncology Nurse-APN/PA (TON), we start our coverage of the news from the recent Oncology Nursing Society (ONS) 40th Annual Congress and the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO). Read More ›